Does GLP-1 use result in significant hair loss?

What the source reports
Experts share what you need to know about GLP-1-related hair loss as the side-effect gets more attention from researchers About 20 million people across the US , UK, and EU are taking GLP-1 receptor agonists like tirzepatide and semaglutide (Ozempic or Mounjaro are common brands) for weight loss and type 2 diabetes.
As their use has surged, we’re learning more about their side-effects. One that’s been getting a lot of attention from researchers lately: hair loss. In one survey of people who take these…
TDBN presents the written preview supplied through the publisher's feed. Complete reporting, continuing updates, context, and corrections remain with the original report.
Read the complete report ↗